Vicarious Surgical (RBOT – Research Report) received a Hold rating and price target from BTIG analyst Ryan Zimmerman today. The company’s shares closed yesterday at $0.38.
Zimmerman covers the Healthcare sector, focusing on stocks such as Glaukos, Vericel, and Zimmer Biomet Holdings. According to TipRanks, Zimmerman has an average return of 3.0% and a 38.54% success rate on recommended stocks.
Currently, the analyst consensus on Vicarious Surgical is a Hold with an average price target of $0.40, which is a 4.17% upside from current levels. In a report released yesterday, Canaccord Genuity also downgraded the stock to a Hold with a $0.40 price target.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $3.85 and a one-year low of $0.32. Currently, Vicarious Surgical has an average volume of 613.8K.
Based on the recent corporate insider activity of 93 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of RBOT in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Vicarious Surgical (RBOT) Company Description:
D8 Holdings Corp is a blank check company.
Read More on RBOT:
